Beam Therapeutics (BEAM)
(Real Time Quote from BATS)
$25.99 USD
-0.63 (-2.37%)
Updated Nov 7, 2024 01:44 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 2/25/25 |
---|---|
Current Quarter | -1.17 |
EPS Last Quarter | -1.17 |
Last EPS Surprise | -3.54% |
ABR | 1.82 |
Earnings ESP
|
-4.33% |
---|---|
Current Year | -4.64 |
Next Year | -4.64 |
EPS (TTM) | -1.76 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 15.95M | 15.31M | 53.59M | 65.83M |
# of Estimates | 6 | 4 | 7 | 6 |
High Estimate | 27.91M | 25.00M | 75.00M | 100.00M |
Low Estimate | 5.00M | 5.00M | 38.50M | 20.00M |
Year ago Sales | 316.19M | 7.41M | 377.71M | 53.59M |
Year over Year Growth Est. | -94.96% | 106.64% | -85.81% | 22.85% |
Earnings Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.17 | -1.16 | -4.64 | -4.64 |
# of Estimates | 8 | 5 | 9 | 7 |
Most Recent Consensus | -0.95 | -0.90 | -4.24 | -3.55 |
High Estimate | -0.95 | -0.90 | -4.24 | -3.55 |
Low Estimate | -1.37 | -1.36 | -4.97 | -5.37 |
Year ago EPS | 1.73 | -1.21 | -1.72 | -4.64 |
Year over Year Growth Est. | -167.63% | 4.13% | -169.77% | 0.07% |
Agreement - Estimate Revisions
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 1 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 4 | 3 | 3 | 3 |
Down Last 30 Days | 4 | 3 | 3 | 3 |
Down Last 60 Days | 4 | 3 | 3 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.17 | -1.16 | -4.64 | -4.64 |
7 Days Ago | -1.11 | -1.09 | -4.60 | -4.43 |
30 Days Ago | -1.11 | -1.09 | -4.60 | -4.43 |
60 Days Ago | -1.11 | -1.09 | -4.60 | -4.43 |
90 Days Ago | -1.14 | -1.14 | -4.64 | -4.58 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.22 | -1.20 | -4.70 | -4.64 |
Zacks Consensus Estimate | -1.17 | -1.16 | -4.64 | -4.64 |
Earnings ESP | -4.33% | -3.38% | -1.17% | 0.07% |
Surprise - Reported Earnings History
Quarter Ending (9/2024) |
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.17 | -1.11 | -1.21 | 1.73 | NA |
Estimate | -1.13 | -1.13 | -1.45 | -1.15 | NA |
Difference | -0.04 | 0.02 | 0.24 | 2.88 | 0.78 |
Surprise | -3.54% | 1.77% | 16.55% | 250.43% | 66.30% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more